Literature DB >> 16680441

[Infection-inflammation-sepsis: state of the art and future perspectives. Tübingen Intensive Symposium, 08.10.2005].

F Schröder1, W A Krueger.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16680441     DOI： 10.1007/s00101-006-1030-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  21 in total

Review 1.  Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control.

Authors:  M J Bonten; D J Austin; M Lipsitch
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

2.  Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit.

Authors:  Saskia Nijssen; Marc J M Bonten; Cory Franklin; Jan Verhoef; Andy I M Hoepelman; Robert A Weinstein
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  Antibiotic rotation and development of gram-negative antibiotic resistance.

Authors:  Harald J van Loon; Menno R Vriens; Ad C Fluit; Annet Troelstra; Christiaan van der Werken; Jan Verhoef; Marc J M Bonten
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

4.  [Infection control measures in intensive care units. Results of the German Nosocomial Infection Surveillance System (KISS)].

Authors:  R-P Vonberg; K Groneberg; C Geffers; H Rüden; P Gastmeier
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

5.  Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.

Authors:  Miguel A de La Cal; Enrique Cerdá; Paloma García-Hierro; Hendrick K F van Saene; Dulce Gómez-Santos; Eva Negro; José Angel Lorente
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

6.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

7.  Rapid detection and identification of pathogens in blood cultures by fluorescence in situ hybridization and flow cytometry.

Authors:  Volkhard A J Kempf; Tanja Mändle; Ulrike Schumacher; Andrea Schäfer; Ingo B Autenrieth
Journal:  Int J Med Microbiol       Date:  2005-04       Impact factor: 3.473

8.  [Incidence of transmission of pathogens in intensive care units. Results of the SIR 3 study].

Authors:  S Bärwolff; H Grundmann; F Schwab; A Tami; M Behnke; C Geffers; E Halle; U Göbel; R Schiller; D Jonas; I Klare; K Weist; W Witte; E Dinger; K Beilecke; H Rüden; P Gastmeier
Journal:  Anaesthesist       Date:  2005-06       Impact factor: 1.041

Review 9.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.

Authors:  H Gerlach; H Lieberman; R Bach; G Godman; J Brett; D Stern
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.